SMIM22 and breast carcinoma: Although no literature data reported information on its involvement in cholestatic diseases or related manifestations, Polycarpou-Schwarz and colleagues demonstrated that small integral membrane protein 22 is involved in actin cytoskeleton organization in the MCF7 breast cancer cell line, affecting cell proliferation, cell migration, and cell cycle progression [30].